Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
19 March 2019 | Story Dr Cinde Greyling
Dr Mutana and Prof Mukwada
Many people enjoy spending time in the mountainous Drakensberg region. Prof Geofrey Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. Pictured here are Dr Sarudzai Mutana with Prof Mukwada.

Not only is the Qwaqwa Campus situated in a beautiful region – its researchers also contribute to keeping the area pristine. Recent research by Prof Geofrey Mukwada and his PhD student, Dr Sarudzai Mutana, focused on indicators monitoring sustainable tourism development in the Drakensberg region.

Dr Mukwada is an Associate Professor in the Department of Geography on the University of the Free State (UFS) Qwaqwa Campus. 

Our majestic mountains are fragile

Many people enjoy spending time in the mountainous Drakensberg region – either as adventure seekers exploring the many trails, or just relaxing and reconnecting with nature. Prof Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. “Mountains are fragile but attractive environments which continue to attract tourists,” he said. “Tourism is one of the major business sectors in the Drakensberg region, with promising growth opportunities and proving to be an anchor of green economy in the future – if practiced correctly.” Unfortunately, the issue of monitoring sustainable tourism has not been widely researched in African mountains. 

According to international standards

“We specifically looked at the Global Sustainable Tourism Criteria (GSTC), which is an international best-practice framework to help destinations monitor and ensure that tourism is developed in a responsible manner,” Prof Mukwada explained. “South Africa’s Manual for Responsible Tourism was designed according to some of the recommendations of the GSTC. But we found that, while the tourism and hospitality operators in the Drakensberg region appreciates the need to monitor and ensure sustainable tourism in the area, there is limited use of indicators as a tool for monitoring.” 

Forward together

There are competing demands between land-use and development practices and alternatives in the region – unless the focus shifts to sustainable practices, the short-term gains could be followed by dire consequences. “We suggest an integrated monitoring of tourism development, with a pro-poor focus that involves more local community leaders. Going forward, we would like to see the industry adopt the indicators proposed in our study.”

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept